Health Care Sector Update for 07/15/2020: CANF, MRNA, NVCR, MRK, XLV, IBB

Health care stocks were gaining in Wednesday's pre-bell trading as both the Health Care SPDR (XLV) and iShares NASDAQ Biotechnology Index (IBB) were recently up more than 1%.

Can-Fite Biopharma (CANF) was advancing by more than 28% after saying it expects to file an investigational new drug (IND) application for piclidenoson as a treatment for COVID-19 patients with moderate symptoms by the end of the month.

Moderna (MRNA) was advancing by over 13%. The company Wednesday said interim results from its early-stage trial of mRNA-1273 vaccine showed immune response against COVID-19 virus, backing its plan for a late-stage trial later this month. The interim analysis was published in The New England Journal of Medicine.

Novocure (NVCR) was up more than 4% after the company and Merck (MRK) unveiled a collaboration to evaluate Novocure's Tumor Treating Fields and Merck's Keytruda as a combination therapy for non-small cell lung cancer. Merck was over 1% higher recently.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.